Shanghai Haohai Biological Technology Co.,Ltd.(688366),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

688366 Shanghai Haohai Biological Technology Co.,Ltd.

Noon Closed 12-24 11:28:26

44.13

-0.12

-0.27%

High44.28	Low44.04	Vol339.36K
Open44.25	D1 Closing44.25	Amplitude0.54%
Mkt Cap10.28B	Tradable Cap8.56B	Total Shares233.00M
T/O14.97M	T/O Rate0.17%	Tradable Shares194.00M
P/B1.83	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"Shanghai Haohai Biological Technology Co.,Ltd.","latestPrice":44.13,"timestamp":1766546906000,"preClose":44.25,"halted":0,"volume":339356,"delay":0,"changeRate":-0.0027,"floatShares":194000000,"shares":233000000,"eps":1.652,"marketStatus":"Noon Closed","change":-0.12,"latestTime":"12-24 11:28:26","open":44.25,"high":44.28,"low":44.04,"amount":14974800,"amplitude":0.0054,"askPrice":44.13,"askSize":30,"bidPrice":44.12,"bidSize":18,"shortable":0,"etf":0,"ttmEps":1.652,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766552400000},"marketStatusCode":3,"adr":0,"adjPreClose":44.25,"symbolType":"stock_kcb","openAndCloseTimeList":[[1766539800000,1766547000000],[1766552400000,1766559600000]],"highLimit":48.68,"lowLimit":39.83,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":232581095,"isCdr":false,"pbRate":1.83,"roa":"--","peRate":26.713075,"roe":"5.39%","epsLYR":1.8,"committee":0.388128,"marketValue":10264000000,"turnoverRate":0.0017,"status":1,"hkstockBrief":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"HAOHAI BIOTEC","latestPrice":25.52,"timestamp":1766549304005,"preClose":25.54,"halted":0,"volume":44135,"delay":0,"premium":"-47.82"},"floatMarketCap":8564000000},"requestUrl":"/m/hq/s/688366/wiki","defaultTab":"wiki","newsList":[{"id":"2593962404","title":"Shanghai Haohai Biological Technology  Says Controlling Shareholder Fined by Securities Regulator Over Insider Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2593962404","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593962404?lang=en_us&edition=fundamental","pubTime":"2025-12-23 18:00","pubTimestamp":1766484049,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4N3XT0I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0251","BK0239","688366"],"gpt_icon":0},{"id":"2593720496","title":"BRIEF-Shanghai Haohai Bio Tech's Controlling Shareholder Fined By Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=2593720496","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593720496?lang=en_us&edition=fundamental","pubTime":"2025-12-23 18:00","pubTimestamp":1766484049,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Haohai Bio Tech's Controlling Shareholder Fined By RegulatorDec 23  - Shanghai Haohai Biological Technology Co Ltd 688366.SS:SAYS CONTROLLING SHAREHOLDER FINED BY SECURITIES REGULATOR OVER INSIDER TRADINGSource textFurther company coverage: 688366.SS  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nL4N3XT0I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2592971160","title":"Shanghai Haohai Biological Repurchases 11,300 Shares at HKD 25.20, Files Disclosure with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2592971160","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592971160?lang=en_us&edition=fundamental","pubTime":"2025-12-18 17:42","pubTimestamp":1766050970,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of a total of 145,300 shares on 12, 17, and 18 December 2025. The repurchases were made at prices ranging from HKD 24.82 to HKD 26.57 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 18, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDL3FNcRD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"1119486263","title":"Haohai Bio Enters Biological Amniotic Membrane Sector: Target Firm Reports Losses, Linked to Controlling Shareholder's Investments","url":"https://stock-news.laohu8.com/highlight/detail?id=1119486263","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119486263?lang=en_us&edition=fundamental","pubTime":"2025-12-14 20:10","pubTimestamp":1765714236,"startTime":"0","endTime":"0","summary":"Amid declining revenue and profits, Shanghai Haohai Biological Technology Co., Ltd. (688366) plans to expand into the biological amniotic membrane market. According to Haohai Bio's latest...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"1160204762","title":"Shanghai Haohai Biological Technology (688366.SH) Plans to Acquire 19.8% Stake in Ruiji Biotechnology","url":"https://stock-news.laohu8.com/highlight/detail?id=1160204762","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160204762?lang=en_us&edition=fundamental","pubTime":"2025-12-12 21:20","pubTimestamp":1765545616,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co., Ltd. (688366.SH) announced its intention to acquire 8.4661 million shares, representing a 19.8% stake, in Jiangxi Ruiji Biological Engineering Technology...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","BK0239","688366"],"gpt_icon":0},{"id":"2590506516","title":"Shanghai Haohai Biological Technology -  Will Acquire 19.8000% Equity Interest in Jiangxi Ruiji Bio-Engineering Technology for RMB38.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2590506516","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590506516?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:29","pubTimestamp":1765542540,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nFWN3XH1J0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["688366","BK0251","BK0239"],"gpt_icon":0},{"id":"2590506312","title":"Shanghai Haohai Acquires 22% Stake in Jiangxi Ruiji Bio-Engineering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590506312","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590506312?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:28","pubTimestamp":1765542489,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has announced the acquisition of approximately 19.8% equity interest in Jiangxi Ruiji Bio-Engineering Technology Co., Ltd. through a share purchase agreement signed on 12 December 2025. Alongside an independent individual investor, who will acquire an additional 2.4554% stake, the total transaction represents about 22.2554% of the target company's shares. The aggregate cash consideration for the transaction is RMB 38,351,487.36 for Shanghai Haohai and RMB 4,755,979.05 for the co-buyer, with the transfer to be completed in three stages between 2025 and 2026. The agreement was entered into with two individual sellers independent of Shanghai Haohai.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL755qLx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688366","BK0239"],"gpt_icon":0},{"id":"2590505180","title":"Shanghai Haohai Biological Technology Appoints New Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2590505180","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590505180?lang=en_us&edition=fundamental","pubTime":"2025-12-12 20:05","pubTimestamp":1765541146,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has announced that Mr. Chiu Ming King has resigned as joint company secretary, authorized representative, and process agent, effective 12 December 2025. Ms. Lai has been appointed to replace him. There are no reported disagreements related to these changes.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDL5JdbxC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"1172873435","title":"Shanghai Haohai Biological Technology Repurchases 51,000 Shares for HK$1.36 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1172873435","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172873435?lang=en_us&edition=fundamental","pubTime":"2025-12-11 18:31","pubTimestamp":1765449088,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co., Ltd. (688366/06826) announced that on December 11, 2025, the company repurchased 51,000 shares for a total of HK$1.36 million. According to the share...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0251","BK0239"],"gpt_icon":0},{"id":"2590164311","title":"Shanghai Haohai Biological Technology Raises Share Capital with 38,529,240 New Shares Issued at HK$68.26 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2590164311","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590164311?lang=en_us&edition=fundamental","pubTime":"2025-12-09 17:27","pubTimestamp":1765272426,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting changes in its issued H shares. As of December 8, 2025, the company's total number of issued H shares stands at 38,529,240. Details regarding the exact number of new shares issued and the issue price per share were not specified in the disclosure.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 09, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL2j9vYl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0239","BK0251"],"gpt_icon":0},{"id":"2588172339","title":"Shanghai Haohai Biological Repurchases 74,900 Shares at HKD 2,061,504 in HKEX Disclosure","url":"https://stock-news.laohu8.com/highlight/detail?id=2588172339","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588172339?lang=en_us&edition=fundamental","pubTime":"2025-12-01 17:27","pubTimestamp":1764581233,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a next day disclosure return to the Hong Kong Stock Exchange, reporting the repurchase of 74,900 shares at a total price of HKD 2,061,504. The repurchases, conducted at a volume-weighted average price of HKD 27.52 per share, are part of the company's ongoing share buyback program.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 01, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL7sQJWc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"2586008622","title":"Shanghai Haohai Biological Technology Repurchases 50,000 Shares at HKD 1,383,426, Files Disclosure to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2586008622","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586008622?lang=en_us&edition=fundamental","pubTime":"2025-11-28 17:12","pubTimestamp":1764321166,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a Next Day Disclosure Return to the Hong Kong Stock Exchange, reporting the repurchase of 50,000 A shares at an average price of HKD 27.67 per share. The aggregate price paid for the repurchased shares was HKD 1,383,426.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on November 28, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL7Pd2yX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"2585045717","title":"Shanghai Haohai Biological Repurchases 36,100 Shares at HKD 27.48 Each in HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2585045717","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585045717?lang=en_us&edition=fundamental","pubTime":"2025-11-24 17:14","pubTimestamp":1763975696,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of a total of 36,100 shares at an aggregate price of HKD 992,172. The shares were repurchased at a price of HKD 27.48 per share and are pending cancellation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief via via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on November 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDL242x7F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0251","688366"],"gpt_icon":0},{"id":"2584692923","title":"Shanghai Haohai Biological Technology Acquires Remaining 20% Stake In Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2584692923","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584692923?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:06","pubTimestamp":1763572002,"startTime":"0","endTime":"0","summary":"Nov 7 (Reuters) - Shanghai Haohai Biological Technology Co Ltd <688366.SS>::*ACQUISITION OF REMAINING 20% STAKE IN UNIT*DEAL FOR RMB74 MILLION*Further company coverage: 688366.SS* ((Reuters.Briefs@tho","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSDf81m1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0251","BK0239"],"gpt_icon":0},{"id":"2584914600","title":"Shanghai Haohai Biological Repurchases 74,900 Shares for HKD 2.05 Million in HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584914600","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584914600?lang=en_us&edition=fundamental","pubTime":"2025-11-19 17:32","pubTimestamp":1763544772,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of 74,900 shares at a total price of HKD 2,048,322, with a repurchase price per share of HKD 27.35. The shares were repurchased for cancellation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief on November 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL1BWq46:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0251","BK0239"],"gpt_icon":0},{"id":"2584664693","title":"Shanghai Haohai Biological Technology Repurchases 121,500 Shares at HKD 27.64 Each in HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2584664693","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584664693?lang=en_us&edition=fundamental","pubTime":"2025-11-17 17:32","pubTimestamp":1763371945,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of a total of 121,500 shares at an average price of HKD 27.64 per share. The aggregate price paid for the repurchased shares was HKD 3,358,184.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief on November 17, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDLchjL2m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688366","BK0239"],"gpt_icon":0},{"id":"2582869821","title":"Shanghai Haohai Biological Files HKEX Disclosure on 15,600 Share Buyback at HKD 27.73 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2582869821","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582869821?lang=en_us&edition=fundamental","pubTime":"2025-11-10 17:38","pubTimestamp":1762767507,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology Co. Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the recent repurchase of a total of 68,700 shares. The shares were repurchased at prices of HKD 27.53 and HKD 27.73 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Haohai Biological Technology Co. Ltd. published the original content used to generate this news brief on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL34zT96:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","688366","BK0251"],"gpt_icon":0},{"id":"2582448188","title":"Shanghai Haohai Biological Technology Purchases Full Stake in Lens Maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2582448188","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582448188?lang=en_us&edition=fundamental","pubTime":"2025-11-10 14:10","pubTimestamp":1762755029,"startTime":"0","endTime":"0","summary":"Shanghai Haohai Biological Technology (HKG:6826, SHA:688366) subsidiary Shanghai Haohai Medical Technology Development purchased the remaining 20% stake in Shenzhen New Industries Material of Ophthalm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1593","06826","06613","688366","BK1170","BK0251","BK1161","BK0239"],"gpt_icon":0},{"id":"2581881623","title":"BRIEF-Shanghai Haohai Biological Technology Acquires Remaining 20% Stake In Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2581881623","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581881623?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:44","pubTimestamp":1762526698,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Haohai Biological Technology Acquires Remaining 20% Stake In UnitNov 7 (Reuters) - Shanghai Haohai Biological Technology Co Ltd 688366.SS:ACQUISITION OF REMAINING 20% STAKE IN UNITDEAL FOR RMB74 MILLIONFurther company coverage: 688366.SS ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688366","BK0239"],"gpt_icon":0},{"id":"2581888137","title":"Shanghai Haohai Biological Technology - Acquisition of Remaining 20% Stake in Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581888137?lang=en_us&edition=fundamental","pubTime":"2025-11-07 22:43","pubTimestamp":1762526603,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nFWN3WJ0R2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0239","688366","BK0251"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-10-30","address":"上海市松江区松江工业区洞泾路5号","stockEarnings":[{"period":"1week","weight":-0.0045},{"period":"1month","weight":-0.0945},{"period":"3month","weight":-0.1422},{"period":"6month","weight":-0.1109},{"period":"1year","weight":-0.2629},{"period":"ytd","weight":-0.2553}],"companyName":"上海昊海生物科技股份有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"23258万元","compareEarnings":[{"period":"1week","weight":0.0249},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.0172},{"period":"6month","weight":0.1367},{"period":"1year","weight":0.1697},{"period":"ytd","weight":0.1695}],"survey":"　　上海昊海生物科技股份有限公司的主营业务是医疗器械和药品研发、生产和销售业务。公司的主要产品是医疗美容与创面护理产品、眼科产品、骨科关节腔粘弹补充剂产品、防粘连及止血产品。","serverTime":1766549641714,"listedPrice":89.23,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Shanghai Haohai Biological Technology Co.,Ltd.(688366),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Shanghai Haohai Biological Technology Co.,Ltd.(688366) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Shanghai Haohai Biological Technology Co.,Ltd.,688366,Shanghai Haohai Biological Technology Co.,Ltd.股票,Shanghai Haohai Biological Technology Co.,Ltd.股票老虎,Shanghai Haohai Biological Technology Co.,Ltd.股票老虎国际,Shanghai Haohai Biological Technology Co.,Ltd.行情,Shanghai Haohai Biological Technology Co.,Ltd.股票行情,Shanghai Haohai Biological Technology Co.,Ltd.股价,Shanghai Haohai Biological Technology Co.,Ltd.股市,Shanghai Haohai Biological Technology Co.,Ltd.股票价格,Shanghai Haohai Biological Technology Co.,Ltd.股票交易,Shanghai Haohai Biological Technology Co.,Ltd.股票购买,Shanghai Haohai Biological Technology Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Shanghai Haohai Biological Technology Co.,Ltd.(688366),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Shanghai Haohai Biological Technology Co.,Ltd.(688366) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}